2021年10月3日Investigational New DrugsKidoguch K, Shibusawa M, Tanimoto TA critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinib2021/7/15
Kidoguch K, Shibusawa M, Tanimoto TA critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinib2021/7/15
コメント